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What does this study/review add to the existing literature and how will it influence 
future clinical practice 
 
This is the largest and most contemporary analysis which demonstrates colonic 
ischaemia (CI) occurs more frequently in open repair (2.1-3.6%) than in EVAR (0.5-
1%) in the elective setting. The majority of cases present within 7 days. There is 
insufficient evidence to determine if there is a difference in rates of reoperation for 
CI between the two techniques but when colectomy is required, the mortality rate is 
high. Most randomised trials of OR vs EVAR do not specifically report colonic 
ischaemia and its sequelae and this should be addressed by future trials given the 
high morbidity and mortality.  
 
ABSTRACT 
 
Introduction 
Colon ischaemia (CI) is a significant complication of open (OR) and endovascular 
(EVAR) repair of abdominal aortic aneurysm (AAA). With a rapid increase in 
EVAR uptake, contemporary data demonstrating the differing rates and 
outcomes of CI between EVAR and OR, particularly in the elective setting are 
lacking. We aimed to characterise the risk and consequences of CI in elective 
AAA repair comparing EVAR with OR. 
 
Method 
A systematic review and meta analysis of the literature was performed using the 
Cochrane collaboration protocol and reported as per the PRISMA guidelines. 
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PubMed, MedLine and EMBASE were searched for studies reporting CI rates 
after elective AAA repair. Ruptured AAA were excluded from analysis. 
 
Results 
13 studies reporting specific outcomes of CI after elective AAA repair, containing 
162750 evaluable patients (78151 EVAR and 84599 OR) were included. All 
studies found a higher risk of CI with OR compared to EVAR. Three studies 
performed confounder adjustment with CI rates of 0.5-1% vs 2.1-3.6% (EVAR vs 
OR) and combined odds ratio of 2.7 (2.0-3.5) for the development of CI with OR 
vs EVAR. The majority of cases of CI occurred within 30 days and are associated 
with variable mortality (0 to 73%) and reintervention rates (27-54%). GRADE 
assessment of evidence strength was very low for all outcomes. There was a high 
degree of heterogeneity between studies both methodologically and in terms of 
CI rates, reintervention, mortality and time to development of CI. 
Conclusions 
EVAR is associated with reduced incidence of CI compared with OR. 
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Introduction 
 
Despite recent advances in the treatment of abdominal aortic aneurysm (AAA) 
the postoperative risk of colonic ischaemia (CI) remains. Colonic ischaemia is a 
serious complication and a significant cause of postoperative mortality. (1-3).  
 
Reported rates of colonic ischaemia after intervention for AAA vary between 
trials, as does its relationship with mortality. It is currently unclear whether CI is 
more common after open repair or EVAR, with overlapping rates quoted in 
different trials (4-7).  Colonic ischaemia has previously been considered to be 
more common after OR than EVAR and looking explicitly at ruptured AAA, a 
Cochrane review found a decreased risk of CI after EVAR as compared to OR 
(Odds ratio 0.39, 95% CI 0.07-2.11), however much of the data was produced by 
a single trial with only 116 patients(8). Furthermore, the acceptance of EVAR has 
increased significantly in the last few years(9, 10) and so the rate of colonic 
ischemia may have changed. 
 
Recent randomised controlled trials of EVAR vs OR were powered to detect 
differences in survival and all cause mortality(11), however, CI is relatively rare 
and there is therefore little high quality or powered data to reflect contemporary 
rates of colonic ischaemia. Furthermore, the incidence of CI may increase with 
time after EVAR, especially with type 2 endoleak intervention and embolization 
of the inferior mesenteric artery. 
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The aim of this meta-analysis was to compare and pool data from the literature 
to identify the contemporary incidence of postoperative colonic ischaemia after 
elective EVAR and open AAA repair, and to assess whether there is a relationship 
between the type of AAA intervention and the time when CI develops.  
 
 Methods 
 
Data sources, search strategy and selection criteria 
A systematic review was undertaken utilising the Cochrane collaboration 
specified protocol(12), and reported as per the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement for the conduct of 
meta-analyses of interventional studies(13). The following sources were searched 
without date restrictions: PubMed, Medline via OVID, Embase, the Cochrane 
Library Database and the Current Controlled Trials register. Details of the protocol 
for this systematic review were registered on PROSPERO and can be accessed at 
www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017069624 
  Studies reporting CI rates after elective AAA repair were included. Exclusion 
criteria included articles where ruptured aneurysms could not be analysed 
separately and aneurysms involving the suprarenal aorta. Definition of colonic 
ischaemia was based on clinically detectable features of ischaemic colitis including 
abdominal pain and bloody diarrhoea with or without endoscopic confirmation. 
There was no limitation on publication type or language in the initial search.  An 
extensive search was also conducted using the 'related articles' function in 
PubMed, of which the results were limited to human research, with review articles 
excluded. The last search date was 10th June 2017. Outcome events were captured 
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when two or more papers presented extractable data. Non-English language 
papers were subsequently excluded, as were papers arising, or suspected of 
arising, from duplicate publications.  
 
 
Data extraction, and outcome measures  
Data extraction and assessment of methodological quality was performed 
independently by two authors. On cases of disagreement a consensus was reached 
amongst all authors.  Extracted data consisted of: first author, year of study, study 
type and design (including if retrospective or prospective, single or multiple 
centres, if consecutive patients were enrolled), number of participants, modality 
of treatment (EVAR or OR), numbers of patients experiencing colonic ischaemia, 
confounder corrected odds ratio or relative risk of colonic ischaemia, number, 
nature and timing of reinterventions for treatment of CI. Where available data 
regarding the perioperative patency, embolization and/or endoleak intervention 
to visceral arteries were extracted. Data were extracted at one year follow up 
where available, or if not given, at maximal follow up.   
Outcome measures were defined as: 
1. CI rate 
2. Mortality related to CI  
3. Reintervention rate for CI and any consequences 
4. Time to CI 
 
Assessment of study quality and evidence rating 
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Study quality was assessed using the Downs and Black checklist, which assigns 
points depending on the quality of design (maximum eleven points), external 
validity (maximum three points), study bias (maximum seven points), 
confounding and selection bias (maximum six points) and study power (maximum 
5 points)(14).  Studies with a score ≥ 17 were considered to be of higher quality. 
Rating of the quality of evidence and strength of recommendation was undertaken 
using the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) system, as per Cochrane collaboration recommendation(15).  Quality 
was assessed depending on: risk of bias, indirectness of evidence, heterogeneity, 
imprecision of results and publication bias. Cohort studies, by definition, have a 
'low' quality of evidence prior to further quality assessment.  The presence of one 
or more serious limitations results in a 'very low' grade of evidence.  A serious 
effect on quality of evidence was considered to occur when >50 per cent of 
included papers evidenced a risk of bias.  Inconsistency was defined as an I2 of 
greater than 50 per cent.  Indirectness was assumed not to occur in this setting.  
Imprecision was defined as less than 150 patients in either cohort. A serious effect 
on quality of evidence was considered to occur when greater than 50 per cent of 
included papers evidenced a risk of imprecision.    
 
Statistical analysis  
 
Meta-analysis was undertaken in Review Manager version 5.3.5 (RevMan; Nordic 
Cochrane Centre, Copenhagen, Denmark).  Meta-analysis was performed for 
dichotomous data where counfounder corrected odds ratios or relative risks were 
available, using odds ratio (OR) as the summary statistic, and reported with 95 per 
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cent confidence intervals (CI), in line with the recommendations of the Cochrane 
Handbook (10). Random-effects models were used where significant 
heterogeneity between studies was detected.  Heterogeneity was assessed using 
an I2 calculation(16). 
 
Our protocol specified that publication bias was to be assessed using funnel plots 
for outcomes with more than ten studies(17), though there were no outcomes 
which satisfied this criterion, so no funnel plots are presented. 
 
Results 
 
Paper search and selection process  
The initial search yielded a total of 1190 results, of which 48 papers were 
retrieved for full evaluation. A total of 13 papers fulfilled the inclusion criteria and 
were included in the subsequent review(1, 4-6, 18-26). See figure 1.  Excluded 
papers of note include 5 studies in which ruptured and elective AAA data could 
not be separated(27-31). There were 3 randomised controlled trials(2, 3, 32) and 
4 retrospective large case series(33-36) in which GI complications of AAA repair 
were reported but no specific data referring to ischaemic colitis were recorded.  
All included studies were case series reporting outcomes of ischaemic colitis after 
elective AAA repair either with EVAR, OR, or both. A total of 84599 OR and 78151 
EVAR were available for evaluation. 
  
Study design and baseline characteristics 
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Study characteristics are given in Table 1. There were 6 studies(1, 4, 5, 24-26) 
comparing outcomes for patients treated with EVAR (76520 patients) and OR 
(80501).  Three of these performed confounder adjustment, one by multivariate 
propensity matching of the cohorts(1) and the other two via multivariate 
modelling (4, 25). There were 4 studies reporting only EVAR(6, 18, 20, 21) (1631 
patients) and 3 studies reporting only OR outcomes(19, 22, 23) (4098 patients). 
Data for patients crossing over from EVAR to OR were not presented in any study. 
Diagnosis of colon ischaemia was made on clinical grounds in all studies with 
endoscopic confirmation in 4 studies(6, 18, 20, 21).  
There were three high quality papers as determined by the Downs and Black 
assessment presented in table 1(2, 6, 19).  GRADE quality assessment was 'very 
low' for all outcomes (Table 3). 
  
Outcomes 
Outcome data for each study are presented in Table 2. 
 
Colonic ischaemia rate 
Thirteen studies reporting specific outcomes of CI after elective AAA repair, 
containing 162750 patients (78151 EVAR and 84599 OR) were included. No 
randomised controlled studies reported specific CI outcomes. Six retrospective 
case studies directly compared CI in elective AAA between EVAR and OR. 
Confounder correction was performed in three of these studies, making them 
suitable for formal meta-analysis (Figure 2).  Colonic ischaemia rates in these 
three studies for EVAR (71186 patients) vs OR (78436 patients) were 0.5% vs 
2.2%(4), 1% vs 2.1%(1) and 0.6% vs 3.6%(25).  
 10 
 
Odds ratios (95% confidence intervals) for the development of CI with OR versus 
EVAR were 2.19 (1.87-2.56)(1), 3.1 (2.7-3.7)(4) and 2.9 (1.8-4.7)(25) in the three 
studies which employed methods to correct for confounding,  giving a combined 
odds ratio of 2.7 (2.0-3.5).   
There was significant heterogeneity between these three studies, both 
methodologically and in terms of rates (I2=80%).  In the three studies which did 
not employ confounder correction, odds ratios were 1.003 (0.997-1.010)(5), 
4.59 (0.55-38.5)(24) and 3.07 (1.17-7.98)(26).  
A further 7 retrospective case series were included in which 3(19, 22, 23) 
reported CI rates in a total of 4098 elective open repairs and 4(6, 18, 20, 21) 
reported CI rates in a total of 1631 elective EVAR. Studies considering open 
repairs consistently published rates of CI which were higher than those studies 
considering EVAR.  
 
CI mortality 
There were 3 studies comparing EVAR to OR and of these, one reported no CI 
related mortality(5) and two reported significant mortality rates in the CI group: 
25/107 (23%) in one study(25) and 370/1941 (19%) in the other(4). In this latter 
paper, mortality associated with colectomy was significantly higher following 
EVAR than OR (73% vs 51%, p<0.05), however, conservative management was 
associated with increased survival following EVAR compared to OR (84% vs 78%, 
p<0.05). There were 4 studies reporting CI mortality in EVAR only patients(6, 18, 
20, 21) and of 27 cases of CI in these 4 papers, 11 patients (41%) died. There were 
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2 studies reporting CI mortality in OR only patients(19, 23) and none of 3 patients 
with CI died. See table 2 for individual study mortality rates.  
 
Reintervention rate for CI  
Re-intervention data were available in 11 papers. See table 2. Six papers reported 
reintervention rates for patients undergoing both EVAR and OR and none 
demonstrated a significant difference in colectomy rates following EVAR 
compared to OR. Reported colectomy rates were variable between 27% and 100%. 
In one(1), specific reintervention rates for colon ischaemia were not available. 
However, rates of bowel resection as a complication of surgery were available and 
patients undergoing EVAR were less likely to undergo a small bowel resection 
than those undergoing OR in the first 4 years post aneurysm repair (3% vs 
3.4%,p<0.05). In 4 papers reporting reintervention rates in 1631 patients 
undergoing EVAR only(6, 18, 20, 21), 11/27 with CI (41%) underwent emergency 
colectomy. A single paper(19) containing 120 patients reporting on OR only 
reported a single patient with CI, treated with surgery.  
 
Time to colonic ischaemia 
Seven studies reported the timing of initial signs and symptoms of colonic 
ischaemia. Hynes et al(26) looked at the timing of re-operations within the first 
30 days, finding that 5/10 patients requiring intervention for CI following OR did 
so within the first 24  hours and the remainder required intervention within the 
first week.  Rates were similar following EVAR, with 4/14 in the first 24 hours, 
13/14 in the first week and only 1 patient requiring reintervention between 7 and 
30 days.  Four papers contained data on timing of development of CI after EVAR 
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without comparison to OR (6, 18, 20, 21).   Eighty one percent (22/27) of these 
cases occurred within 30 days and nineteen percent (5/27) occurred after 30 days. 
Limited data was available for CI in OR without comparison to EVAR, with only 2 
studies reporting on 423 patients undergoing OR. These reported 2 cases of CI, 
one of which was at 11 days and one was after 30 days(5, 19).  
 
Perioperative visceral arterial status 
There was a single study reporting the effect of endoleak on CI and found colonic 
ischaemia was associated with type 3 but not type 2 endoleak at the end of the 
procedure(25). It was not possible to determine if reintervention was performed 
in these cases. Four studies recorded the preprocedure  IMA patency and 
whether IMA embolization had been performed(6, 18, 21, 25). It was not 
possible to extract data to draw specific comparisons of the effect of IMA 
embolization on CI, however in one paper, all patients who went on to develop CI 
following EVAR had patent IMA preoperatively(21) whereas the others reported 
between 62% and 91% of those who developed CI following EVAR had pre-
existing IMA occlusions. Six studies reported on the effect of internal iliac artery 
(IIA) embolization on CI. Of these, 2 reported a higher risk of CI with unilateral 
IIA embolization(18, 25), whereas 4 studies reported no difference in risk of CI 
with either uni or bilateral IIA embolization(6, 20, 21, 24).  
 
 
  
 
Discussion 
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This analysis has identified several case series, which have compared CI rates 
between elective EVAR and OR.  These studies are of variable quality, GRADE 
assessment was very low for all outcomes and only three performed any type of 
confounder adjustment. Meta-analysis of results from these studies suggests that 
CI rates may be significantly higher after OR than EVAR.  The outcome data for 
over 150000 patients in 11 studies also demonstrate a clear advantage of EVAR 
in terms of reduced frequency of CI. Although it was not possible to control for 
factors such as comorbidity or IMA status, it is clear that in general EVAR carries 
a lower risk of CI.   
 
These results are comparable to a recent review by Lee et al(37) who found a 
reduced likelihood of CI after EVAR compared to OR (Relatve Risk 0.22, 0.12-
0.39, p<0.001), although this analysis included both ruptured and elective AAA 
and contained older studies with a smaller number of patients and did not 
employ confounder correction. For ruptured AAA, a recent Cochrane review 
found a decreased risk of CI after EVAR as compared to OR (Odds ratio 0.39, 95% 
CI 0.07-2.11), however this relied upon a single randomised trial with only 116 
patients (8, 38). 
 
Perioperative mortality was significantly lower in EVAR vs OR in a recent meta-
analysis of four randomised trials comparing EVAR with OR(11), however, this 
early survival advantage is lost at 3 years, mainly due to aneurysm specific 
complications, although patients with low ABPI experienced worse long term 
survival with EVAR compared to OR.  There was insufficient data to determine 
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whether colonic ischaemia was a factor in this. From our analysis, when CI 
occurs, it is usually identified within 30 days and is associated with a significant 
mortality rate, particularly where colectomy is required and it may be that 
earlier recognition and treatment of this condition could improve outcomes.  
It was noted that of several large randomised controlled trials, there were no 
available data for CI rates; instead the authors reported less specific 
complications such as need for re-laparotomy or GI intervention (2, 3, 32, 39, 
40). Of note, there was an increased risk of small bowel resection following OR 
than EVAR in one large series and although the cause was not identified, there 
was an associated increased risk of adhesional and hernia related bowel 
obstruction after OR and this is likely to be related. There were insufficient data 
to determine whether reintervention rates for treatment of CI differed between 
OR and EVAR and were broadly similar in the larger series.  We therefore 
recommend that future RCT’s specifically report CI outcomes when comparing 
both procedures given the high mortality resulting from this condition. This is 
particularly important as there is emerging evidence that more patients with 
prohibitive risk factors for surgery are being offered EVAR(41). The benefit of a 
selective approach to EVAR use in more frail patients is not clear (42) and the 
relative contributions of comorbidity and specific complications such as CI to 
survival and long term outcomes from both EVAR and OR will be more difficult 
to interpret.  
The physiological basis of CI after AAA repair is likely multifactorial and this may 
explain the differences in CI rates between procedures. In open surgery a 
significant factor is aortic cross clamping giving rise to ischaemia and 
reperfusion injury of the colon. One study found a 3 fold increase in colonic 
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mucosal apoptosis in biopsies obtained immediately after surgery as compared 
to EVAR as well as significant rises in peripheral proinflammatory cytokines 
including TNF alpha compared with no evidence of apoptosis and much lower 
cytokine release following EVAR(43) . In the case of EVAR, a possible cause of CI 
is sacrifice of the inferior mesenteric and rarely, the internal iliac arteries. The 
effect of IMA sacrifice on CI is not clear and is commonly performed in both 
EVAR and OR. One study attempted to address this by randomising 160 patients 
to IMA ligation or reimplantation during OR and found no difference in CI 
rates(44). During EVAR, occasionally one and rarely both internal iliac arteries 
may be sacrificed. A case control study demonstrated a tendency towards higher 
risk of CI after bilateral internal iliac artery ligation as opposed to unilateral 
ligation in open surgery(28). However, a review of 278 EVARs found that of the 8 
patients who developed CI, only one had undergone internal iliac artery 
embolization and the remaining 121 who underwent uni or bilateral internal 
iliac embolization had no evidence of CI(6). Furthermore, of the 8 with CI, 4 
displayed evidence of distal microvascular emboli within colonic arterioles 
presumed a result of dislodged atheroma from the aorta or access vessel. 
Preoperative imaging demonstrated IMA occlusions in 3 of 4 patients and the 
embolic pathway was therefore presumed to be via patent internal iliac arteries.  
In the present analysis, data regarding the effect of perioperative visceral arterial 
embolization were limited and contradictory and no firm conclusions can be 
drawn from the available literature. Various techniques have been employed to 
improve detection and reduce the risk of CI including intraoperative IV 
fluorescein(45), early postoperative sigmoidoscopy(7) and intraoperative laser 
doppler flowmetry(46) although none have yet entered routine clinical practice.  
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Furthermore, as there is no ability to observe the colon during the EVAR 
procedure, detection of CI is difficult initially which may lead to delayed 
diagnosis with more serious consequences, whereas during open surgery, colon 
ischaemia may be detected intraoperatively and measures such as colectomy or 
IMA reimplantation undertaken which will affect reported CI rates. .  
 
 
Factors contributing to CI are emergency open repair for rupture and associated 
parameters such as blood loss, pre-existing renal and respiratory morbidity and 
length of surgery (27, 30, 47).  
 
The strengths of the current analysis are that a large number of patient outcomes 
were available for analysis and all demonstrated a higher rate of CI with OR. 
However, most studies were poorly designed with limited or no evidence of 
cohort matching. Most did not clearly describe how colonic ischaemia was 
diagnosed and definitions were largely based on clinical grounds with only 
limited description of endoscopic confirmation.  
It is notable that many studies did not report the timing of onset of CI. Most 
studies did not employ routine post operative sigmoidoscopy and it is possible 
that minor and self limiting CI may not have been detected in some series and 
only those with severe CI included in the analysis thereby increasing the 
reported mortality and reintervention rates. Furthermore, several papers 
reported onset of CI more than 30 days after initial treatment and it is possible 
that this represents a different pathological process and it was not possible to 
accurately confirm this from the data available. A sensitivity analysis was not 
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possible due to the limited number of directly comparable studies.  Furthermore, 
it was not possible to extract and meta analyse data for confounding factors such 
as renal impairment, comorbidity, management of endoleaks, IMA ligation 
and/or reimplantation, transfusion requirements, length of stay and operative 
time or technique including use of intraoperative Doppler monitoring of colonic 
perfusion or mesenteric artery reimplantation. 
Conclusion 
In an elective setting, EVAR is associated with reduced frequency of CI compared 
with OR. CI is associated with significant mortality. When emergency colectomy 
is required, the mortality rises to over 50% in most studies. It is not clear if there 
is a difference in CI related mortality or colectomy rates between EVAR and OR, 
however, when it does occur, most cases present within 7 days for both 
procedures.   
 
Figure Legends 
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Figure 2. Forest plot comparing rates of CI between OR and EVAR in studies 
employing techniques for multivariate confounder correction.  Higher odds 
ratios imply higher rates among patients undergoing OR.  Heterogeneity: Tau² = 
0.05; Chi² = 10.06, df = 2 (P = 0.007); I² = 80%.  Test for overall effect: Z = 6.81 (P 
< 0.00001). 
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Table 1. Table 1. Study Characteristics, demographic data and Downs and Black 
scores for each paper. Outcome 1. Colon ischaemia (CI) rate, 2. CI mortality rate, 
3. Reintervention rate, 4. Time to CI  
 
Table 2. Outcome data for each study 
 
 
Table 3. GRADE analysis and assessment of quality of evidence.  Risk of bias was 
assessed for each included paper, and was assumed to be present when a non-
consecutive, or non-propensity matched cohort was analysed, or follow up did not 
reach 12 months.  
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